Japan’s MHLW Steps Up Efforts To Reduce Drug Approval Lag Time
This article was originally published in PharmAsia News
Executive Summary
TOKYO - On the back of rising pressures, Japan's Ministry of Health, Labor and Welfare is stepping up efforts to shorten new drug approval periods that now are woefully behind other countries - yet finds the undertaking a tall task that may take longer than officials envisioned
You may also be interested in...
Japan's MHLW Enhances Role Of Innovation In Drug Pricing, USTR Says
WASHINGTON - Japan is giving more weight to innovation when pricing new drugs
Japan's MHLW Enhances Role Of Innovation In Drug Pricing, USTR Says
WASHINGTON - Japan is giving more weight to innovation when pricing new drugs
Japan's Health Ministry Improves Drug Pricing For Innovators
Japanese agency creates new anti-cancer drugs division and adds personnel to speed up drug reviews, U. S. Trade Representative reports.